Resmed (RMD) shares led the S&P 500 higher, skyrocketing 18.9% after the health care technology company posted better-than-expected quarterly revenue and earnings results. Demand for Resmed's products remained strong, particularly its sleep devices, and the company refuted concerns that the growing use of weight-loss drugs could subdue sales.
Resmed (RMD) shares led the S&P 500 higher, skyrocketing 18.9%...
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$32.97 |
Change
0.000(0.00%) |
Mkt cap ! $21.03B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1800 | $34.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $31.33 | 5918 | 3 |
View Market Depth
| Last trade - 09.47am 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$32.26 |
Change
0.000 ( 2.06 %) |
||||
| Open | High | Low | Volume | ||
| $32.22 | $32.31 | $32.18 | 3611 | ||
| Last updated 10.08am 09/05/2024 ? | |||||
| RMD (ASX) Chart |
Day chart unavailable